Chemokine-like Factor 1: A Promising Therapeutic Target in Human Diseases

Overview

Journal Exp Biol Med (Maywood)

Specialty Biology

Date 2020 Jul 28

PMID 32715782

Citations 13

Authors

Xiaopeng Cai

Jingwen Deng

Qianqian Ming

Huiqiang Cai

Zhi Chen

Affiliations

Soon will be listed here.

Abstract

CKLF1, a recently identified chemokine, has been reported by a number of studies to play important roles in quite many diseases. However, the potential pathways that CKLF1 may be involved are not manifested well yet. In our review, we showed the basic molecular structure and major functions of this novel chemokine, and implication in human diseases, such as tumors. To attract more attention, we summarized its signaling pathways and clearly present them in a set of figures. With the overview of the experimental trial of CKLF1-targeting medicines in animal models, we hope to provide a few important insights about CKLF1 to both medical researchers and pharmacy.

Citing Articles

Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer.

Tian Y, Xie Y, Yi G, Wu F, Dang X, Bai F Curr Med Chem. 2024; 31(42):7043-7058.

PMID: 39129286 DOI: 10.2174/0109298673315146240731100101.

Utility of serum chemokine-like factor 1 as a biomarker of severity and prognosis after severe traumatic brain injury: A prospective observational study.

Wu X, Su C, Tian D, Ye Y, Du Q, Chen J Brain Behav. 2024; 14(5):e3522.

PMID: 38773776 PMC: 11109498. DOI: 10.1002/brb3.3522.

CKLF induces microglial activation via triggering defective mitophagy and mitochondrial dysfunction.

Wang H, Ye J, Peng Y, Ma W, Chen H, Sun H Autophagy. 2023; 20(3):590-613.

PMID: 37908119 PMC: 10936627. DOI: 10.1080/15548627.2023.2276639.

Regulation of oxygen-glucose deprivation/reperfusion-induced inflammatory responses and M1-M2 phenotype switch of BV2 microglia by lobetyolin.

Wang J, Liu X, Wei W, Yang J, Li Q, Chu S Metab Brain Dis. 2023; 38(8):2627-2644.

PMID: 37837601 DOI: 10.1007/s11011-023-01292-6.

Current Opinions on the Relationship Between CMTM Family and Hepatocellular Carcinoma.

Pei Y, Zhang Z, Tan S J Hepatocell Carcinoma. 2023; 10:1411-1422.

PMID: 37649636 PMC: 10464892. DOI: 10.2147/JHC.S417202.

References

Li J, Bao X, Li Y, Wang Y, Zhao Z, Jin X . Study of the functional mechanisms of osteopontin and chemokine-like factor 1 in the development and progression of abdominal aortic aneurysms in rats. Exp Ther Med. 2017; 12(6):4007-4011. PMC: 5228271. DOI: 10.3892/etm.2016.3891. View

Xia D, Li X, Lou Y, Han W, Ding P, Zhang Y . Overexpression of chemokine-like factor 2 promotes the proliferation and survival of C2C12 skeletal muscle cells. Biochim Biophys Acta. 2002; 1591(1-3):163-173. DOI: 10.1016/s0167-4889(02)00270-7. View

Jiao Y, Shen C, Zhang X . [The expression of chemokine-like factor 1 in human atherosclerotic plaques]. Zhonghua Wai Ke Za Zhi. 2010; 47(21):1654-7. View

Rui M, Xia D, Zhang Y, Han W, Wang L, Ding P . Molecular cloning and characterization of four isoforms of mCKLF, mouse homologues of human chemokine-like factor. Mol Biol Rep. 2003; 30(4):229-37. DOI: 10.1023/a:1026308129769. View

Liu Y, Zhang S, Ling X, Li Y, Zhang Y, Han W . Analysis of the interactions between the peptides from secreted human CKLF1 and heparin using capillary zone electrophoresis. J Pept Sci. 2008; 14(8):984-8. DOI: 10.1002/psc.1028. View

Dinarello C . Historical insights into cytokines. Eur J Immunol. 2007; 37 Suppl 1:S34-45. PMC: 3140102. DOI: 10.1002/eji.200737772. View

Cheng A, Han W, Ma D, Lou S . [Effects of chemokine-like factor 1 (CKLF1) on proliferation and metabolism of chondrocytes]. Beijing Da Xue Xue Bao Yi Xue Ban. 2003; 35(4):399-401. View

Sakalihasan N, Limet R, Defawe O . Abdominal aortic aneurysm. Lancet. 2005; 365(9470):1577-89. DOI: 10.1016/S0140-6736(05)66459-8. View

Wang Y, Zhang Y, Yang X, Han W, Liu Y, Xu Q . Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4). Life Sci. 2005; 78(6):614-21. PMC: 7126766. DOI: 10.1016/j.lfs.2005.05.070. View

10.

Tan Y, Han W, Chen Y, Ouyang N, Tang Y, Li F . Chemokine-like factor 1, a novel cytokine, contributes to airway damage, remodeling and pulmonary fibrosis. Chin Med J (Engl). 2004; 117(8):1123-9. View

11.

Han W, Lou Y, Zhang Y, Chen Y, Li Y, Gu W . Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. Biochem J. 2001; 357(Pt 1):127-35. PMC: 1221935. DOI: 10.1042/0264-6021:3570127. View

12.

Li G, Li G, Wang Z, Ji H, Wang D, Hu J . The chemokine-like factor 1 induces asthmatic pathological change by activating nuclear factor-κB signaling pathway. Int Immunopharmacol. 2014; 20(1):81-8. DOI: 10.1016/j.intimp.2014.02.014. View

13.

Zheng Y, Guo C, Zhang Y, Qi H, Sun Q, Xu E . Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1). Int Immunopharmacol. 2011; 11(12):2188-93. DOI: 10.1016/j.intimp.2011.09.017. View

14.

Kong L, Wang Z, Hu J, Yuan Y, Han N, Li H . Inhibition of chemokine-like factor 1 protects against focal cerebral ischemia through the promotion of energy metabolism and anti-apoptotic effect. Neurochem Int. 2014; 76:91-8. DOI: 10.1016/j.neuint.2014.07.004. View

15.

Yu M, Qi B, Xiaoxiang W, Xu J, Liu X . Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway. Biomed Pharmacother. 2017; 90:677-685. DOI: 10.1016/j.biopha.2017.04.001. View

16.

Han W, Ding P, Xu M, Wang L, Rui M, Shi S . Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation. Genomics. 2003; 81(6):609-17. DOI: 10.1016/s0888-7543(03)00095-8. View

17.

Martinez-Cuadron D, Boluda B, Martinez P, Bergua J, Rodriguez-Veiga R, Esteve J . A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia. Ann Hematol. 2018; 97(5):763-772. DOI: 10.1007/s00277-018-3229-5. View

18.

de Zeeuw D, Bekker P, Henkel E, Hasslacher C, Gouni-Berthold I, Mehling H . The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial. Lancet Diabetes Endocrinol. 2015; 3(9):687-96. DOI: 10.1016/S2213-8587(15)00261-2. View

19.

Lou Y, Xia D, Han W, Wang Y, Li X, Li Y . Molecular cloning and characterization of rat chemokine-like factor 1 and 2. Gene. 2003; 307:125-32. DOI: 10.1016/s0378-1119(03)00450-5. View

20.

Harashima N, Inao T, Imamura R, Okano S, Suda T, Harada M . Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells. Cancer Immunol Immunother. 2011; 61(5):667-76. PMC: 11029084. DOI: 10.1007/s00262-011-1132-1. View